Shandong Boan Biotechnology Co., Ltd clinical trials

Acquired by Luye Pharma Group Ltd., Feb 17, 2020 · source ↗

The registry lists 8 studies whose lead sponsor is Shandong Boan Biotechnology Co., Ltd. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.

Before and after it joined Luye Pharma Group Ltd.

First submitted before Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.: 0
First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.: 8
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Recruiting: 5
Completed: 2
Active, not recruiting: 1

Phase

Phase 1: 7
Phase 3: 1

Where

China: 7
Germany: 1

Registry sponsor names on this page

Shandong Boan Biotechnology Co., Ltd8 studies

Something wrong with this grouping? Tell us on the Luye Pharma Group Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 8 of 8. All Luye Pharma Group Ltd. studies →

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1203 in Advanced Solid Tumors.RecruitingNCT07876609Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsRecruitingNCT06596915Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.RecruitingNCT06927349Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid TumorsRecruitingNCT05650242Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
A Study of BA1202 in Patients With Advanced Solid TumorsRecruitingNCT05909241Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous InjectionCompletedNCT06095427Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06022861Phase 3
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.
Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male SubjectsCompletedNCT05110118Phase 1
Sponsor listed in the registry: Shandong Boan Biotechnology Co., Ltd · First submitted after Shandong Boan Biotechnology Co., Ltd became part of Luye Pharma Group Ltd.